Дип Хит

Quick links to important sections

Дип Хит

Selected form

Method of action: Analgesic, Anti-Inflammatory

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Дип Хит

Quick Facts

Property Description
Active Ingredients Methyl Salicylate, Menthol, Eucalypti Oleum, Terpentine Oil
Form Liniment, Cream, Oil, Balm (Topical)
Pharmacological Class External Analgesic, Topical Rubefacient
Common Use Temporary relief of minor musculoskeletal aches and strains
Origin Derived (Combination of natural essential oils and a synthetic derivative)

Defining Дип Хит: Classification and General Purpose

Дип Хит (Deep Heat) is a Multicomponent preparation classified as an External Analgesic and a Topical Rubefacient, formulated for localized, temporary symptomatic relief of minor musculoskeletal pain. This preparation is typically available as an Over-the-Counter (OTC) Drug, intended solely for Topical (Cutaneous) application. Its general purpose is rooted in providing comfort for common aches, stiffness, and tension associated with muscles and joints, often used in scenarios following routine physical activity or during flare-ups of chronic conditions. Topical rubefacients are recognized for their action in relieving localized muscle and joint discomfort by engaging peripheral sensory mechanisms.

Active Ingredients and Compositional Type

This combination product is defined by its four principal Active ingredients [INN]: Methyl Salicylate, Menthol, Eucalypti Oleum, and Terpentine Oil. The formulation is derived, utilizing active compounds from natural essential oils alongside Methyl Salicylate, a well-known topical analgesic. The product is supplied in multiple Dosage form(s), including a Liniment, Cream, Oil, and Balm, offering patients different formats for administration based on preference.

The Principle of Counter-Irritation

The functional essence of the preparation is Counter-Irritation, the core mechanism through which it provides temporary symptomatic relief. The specific blend of active ingredients is engineered to produce a potent dual-sensory experience: an initial cooling sensation provided by Menthol followed by a pronounced warming sensation. This strong activation of superficial sensory nerves serves as a physiological distraction mechanism, effectively reducing the user’s perception of underlying discomfort. Essential oils such as Eucalypti Oleum are used to relieve localized muscle pain, consistent with their established role in these types of topical preparations.

Regulatory References

  1. EMA scientific guideline on cutaneous products

What side effects are possible with Дип Хит?

Possible Side Effects and Safety Information

The regulatory safety profile for this topical preparation is chiefly defined by localized cutaneous reactions at the application site. Systemic adverse reactions are documented, but are primarily associated with excessive absorption or ingestion. This information is based on official government regulatory documents for topical products containing methyl salicylate and menthol.

Adverse Reactions and Classifications

Adverse reactions listed in official labeling mainly affect the Skin and Subcutaneous Tissue Disorders system-organ class. These localized effects may include a temporary burning sensation, redness (erythema), and local skin irritation or pruritus (itching). The incidence of effects like blistering, swelling, or increased pain at the application site is not known.

Serious Adverse Reactions are classified as rare. These include documented cases of first- to third-degree chemical burns at the application site. A severe systemic risk is salicylate poisoning (systemic toxicity), which may occur following excessive topical use or ingestion and can present with symptoms such as tinnitus (ringing in the ears), nausea, and confusion.

Safety Constraints and Special Populations

Official safety documents place important constraints on the use of the product. Application is restricted to intact skin and must not be used on broken, damaged, or irritated skin, wounds, or open cuts. The risk of adverse effects, including burns, is heightened and its use is prohibited with external heat sources, such as heating pads or tight bandaging.

Population-Specific Safety Notes include restrictions for children and teenagers under 18 who have chickenpox, flu, or undiagnosed illness, due to the theoretical risk of Reye's syndrome from systemic absorption of methyl salicylate. Additionally, use is generally not recommended during the third trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation defines the overdose profile for this topical rub (containing Methyl Salicylate and Menthol) based on two primary risks: systemic toxicity following ingestion and severe local tissue damage from misuse.


Overdose Manifestations and Required Actions

Classification Official Regulatory Wording / Basis
Documented Overdose Presentation Early signs of systemic toxicity (salicylate poisoning) may include tinnitus, vomiting, dizziness, and hyperventilation.
Severe Outcomes Life-threatening outcomes include seizures, coma, non-cardiac pulmonary oedema, and acute kidney failure. Third-degree chemical burns are documented as a potential severe local complication.
Population-Specific Notes Patients under ten years and those over 70 years are officially noted to have an increased risk of salicylate toxicity.

When to Seek Urgent Medical Help

Immediate medical assistance is mandated if the product is swallowed or if the patient exhibits signs of serious systemic toxicity, such as passing out or trouble breathing. Regulatory agencies require users to stop use and seek medical attention immediately upon the development of pain, swelling, or blistering of the skin, indicating potential severe local injury. The treatment approach is officially defined as symptomatic and supportive, as no specific antidote is known for this toxicity. Procedures include monitoring of salicylate levels and enhanced elimination methods like haemodialysis.

Therapeutic Uses of Дип Хит

What Дип Хит Treats: Main Uses and Benefits

The preparation is commonly used across conditions presenting with acute or recurrent episodes of minor musculoskeletal discomfort. This supportive relief is applicable in contexts marked by increased discomfort or tension in the soft tissues and joints.

The therapeutic benefit is generally associated with addressing symptoms related to physical discomfort, which may include muscular aches, stiffness, strains, sprains, and minor rheumatic or arthritic joint pain. When symptoms become more noticeable, the preparation helps address symptom clusters that may become intense or disruptive. It is commonly used during phases when short-term symptomatic assistance is needed, and is relevant in contexts involving, for instance, post-exertion soreness or simple backache.

The primary therapeutic purpose is to provide support that helps ease the overall symptom burden, which may help patients cope more steadily with symptom fluctuations. “It contributes to improved day-to-day comfort during periods of heightened symptoms and may assist with maintaining a sense of functional stability.”


Quick Fact: Relief for Musculoskeletal Discomfort
Primary Focus: Localized muscular aches and strains.
Secondary Focus: Minor joint stiffness and non-specific backache.
Symptom Level: Generally considered relevant for managing mild to moderate temporary discomfort.
Context of Use: Post-exertion soreness and episodic flare-ups.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Дип Хит

This section outlines the officially documented population eligibility and non-eligibility rules for this topical medicine, based strictly on government regulatory documents.


Category Regulatory Status Constraint Details
Pediatric Use Contraindicated Prohibited for children under 5 years old.
Adolescent Use Conditionally Prohibited Not to be used by teenagers under 18 with chickenpox, flu, or undiagnosed illness (risk of Reye's syndrome).
Skin Condition Contraindicated Must not be applied to broken, damaged, infected, or irritated skin or open wounds.
Hypersensitivity Contraindicated Prohibited for individuals with an allergy to any ingredient, or to aspirin and other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs).
Late Pregnancy Prohibited Must not be used after 30 weeks of pregnancy; use between 20 and 30 weeks is restricted and requires a doctor's direction.
Lactation Restricted Use requires consulting a healthcare professional.
Comorbidities Restricted/Use with Caution Consultation required for patients with asthma, nasal polyps, severe kidney disease, or those taking anticoagulants (blood thinners).

The regulatory structure defines who can and cannot use this medicine by establishing absolute prohibitions (contraindications) based on age, allergy history, and skin integrity. It also sets conditional restrictions for specific physiological states (pregnancy/lactation) and comorbid conditions, which collectively determine the final population eligible for its use.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory information regarding Дип Хит focuses on interaction risks stemming from the potential systemic absorption of its active ingredient, Methyl Salicylate, which is a salicylate derivative. The primary concern is a pharmacodynamic interaction and restrictions designed to mitigate exposure.

Documented Interaction Profile

Category Regulatory Statement
Interacting Drug Class Oral Anticoagulants (e.g., Warfarin)
Interaction Type Pharmacodynamic Potentiation
Interaction Outcome Increased effect of coumarin anticoagulants, leading to an increased risk of bleeding

Administration Restrictions to Mitigate Risk

Official labeling mandates specific administration constraints related to the potential for enhanced systemic exposure and additive effects. The product must not be used in combination with other external analgesic products to prevent potentially dangerous additive effects. Additionally, the label explicitly restricts use with heating pads, other heat sources, or immediately after a hot shower or bath. These conditions can significantly enhance skin absorption, thereby increasing the level of circulating Methyl Salicylate and elevating the potential for the aforementioned systemic drug interaction.

Mechanism of Action

The preparation utilizes a dual-mechanism consisting of peripheral sensory modulation and local anti-inflammatory pathway inhibition.

Modulating Pain Signaling via Counter-Irritation

This mechanism focuses on activating superficial nerve receptors to create high-intensity sensory input. Menthol acts as an agonist on the Transient Receptor Potential Melastatin 8 (TRPM8) ion channel , generating a false cooling sensation that causes the high-intensity sensory input to compete with the slower-transmitting nociceptive signals in the central nervous system. This neuromodulation alters the central processing of the original nociceptive signal.

Local Suppression of Inflammatory Mediators

The second mechanism addresses the biochemical drivers of nociception. Methyl Salicylate is metabolized into Salicylic Acid, which acts as a non-selective inhibitor of the Cyclooxygenase (COX) enzymes . By blocking the synthesis of prostaglandins, this action reduces the concentration of pro-inflammatory mediators, influencing the underlying peripheral nociceptive signaling. The biochemical effect is sustained for a longer duration than the immediate sensory modulation.

Increasing Local Blood Flow (Rubefaction)

Rubefacients stimulate sensory nerves and trigger a localized neurovascular reflex. This causes vasodilation (widening of superficial blood vessels) and leads to cutaneous hyperemia (increased blood flow), which reinforces the counter-irritation mechanism and may facilitate changes in muscle tone associated with increased local blood flow.

Dosage and Administration Information

How to use Дип Хит: Official Administration Guidelines

This section outlines the official, label-based instructions for the use of Дип Хит topical preparations.


Administration Scope

Feature Official Instruction
Route of administration Topical (Cutaneous) administration only.
Dosing schedule Apply a thin layer to the affected area. For spray formulations, use 2 to 3 short bursts per application site.
Frequency and duration Apply to the painful area not more than 3 to 4 times daily. Discontinue use if pain persists for more than 7 days.
Age-group rules Approved for use in Adults and Children 2 years of age and older. Use in children under two years requires a doctor's consultation.

Procedural and Use-Context Constraints

Administration steps:

  • Apply a thin layer or limited spray bursts directly to the site of pain.
  • Rub in the preparation thoroughly until it is fully absorbed into the skin.
  • Wash hands immediately following administration, unless the hands are the area being treated.

Use-context constraints:

Standard instructions specify that the treated area must not be covered with tight bandages and must not be exposed to external heat sources, such as heating pads, sunlamps, or hot water bottles. The product is designated for short-term, temporary symptomatic relief in accordance with these parameters.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Дип Хит

Evidence for Use in Acute Musculoskeletal Pain

Research exploring topical rubs containing active components like methyl salicylate and menthol primarily consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews. These trials were generally used in research exploring how symptoms change over time in adults presenting with acute or disruptive episodes of localized pain. The studies monitored patient-reported outcomes describing perceived discomfort over brief time intervals, typically around one week.

Some studies reported patterns of change in pain scores when comparing the active formulation to a placebo control. However, findings were mixed across various scientific reviews, with some suggesting a difference in measured outcomes while others found the evidence is limited and heterogeneous. A key consideration is that the follow-up durations were limited, with most data reflecting observations over only 3 to 7 days.

Evidence for Use in Chronic Musculoskeletal Discomfort

For chronic, longer-standing issues like non-specific backache or joint discomfort, the evidence is limited and the certainty remains low. Research examined conditions characterized by fluctuating or episodic manifestations over intermediate time frames. Systematic reviews have reported that in trials examining sustained management, sample sizes were modest and evidence quality varies across studies. For chronic pain, large-scale research often describes patterns of change that were not substantially different from the placebo control, suggesting that certainty remains low for drawing firm conclusions.

Long-Term Research and Study Follow-up

Research provides context for short-term symptom changes but is heavily weighted toward short-term observation. There is limited information for long-term outcomes or durability of any observed response. Research has not yet established whether the product is associated with sustained observations related to physical discomfort over extended time periods; this is an area where data are still emerging and research is ongoing.

What is Still Uncertain About the Research for Дип Хит

The research available highlights what is known and what is still uncertain. A major gap is the limited information available for the long-term effects and sustained use of these products. Furthermore, comparative evidence is lacking—few studies directly examine the specific four-ingredient combination against other topical products. Although research has explored outcomes related to physical discomfort, the evidence quality varies across studies, leading to mixed findings and low certainty in conclusions for some chronic conditions.

Frequently Asked Questions (FAQ)

Common questions about Дип Хит (FAQ)

Q: How long does it usually take for Дип Хит to start working?

Official information classifies this product as an External Analgesic and Topical Rubefacient. This means its functional purpose is to provide effects following application to offer temporary symptomatic relief from minor aches and strains.


Q: Is it okay to use Дип Хит after exercising?

Official usage information states that the product can be used both before or after physical exercise. This is consistent with its intended use for minor aches and strains associated with physical activity.


Q: What is the difference between Дип Хит cream and the spray/roll-on options?

The active ingredients are the same across all different dosage forms, such as the cream, spray, and liniment. The main regulatory difference is the administration method, which is defined by the product label as either applying a thin layer of cream or using short bursts of spray.


Q: What should I do if I accidentally get Дип Хит in my eyes?

Official safety documents contain the instruction to wash the affected area with plenty of clean water immediately. This precaution is necessary to prevent the transfer of the active ingredients to sensitive areas like the eyes or lips.


Q: Is there a maximum area of the body you can cover with Дип Хит?

Regulatory instructions limit application to the 'affected area' using only a 'thin layer' of the product. Applying the product to an excessively large area increases the risk of systemic absorption, which can potentially lead to toxicity.


Q: What does 'for external use only' really mean for Дип Хит?

The classification 'for external use only' means the product is strictly limited to topical use on the skin. This constraint is in place because swallowing the product can cause severe systemic toxicity, such as salicylate poisoning.


Q: Has Дип Хит ever been recalled or flagged for safety issues?

Regulatory documentation for this product class includes records of specific actions. A specific spray formulation was subject to regulatory action, such as cancellation, based on a sponsor's decision.


Q: Does Дип Хит contain any ingredients that are banned in sports?

The product's active ingredients are Methyl Salicylate and Menthol. According to the current information from major bodies like the World Anti-Doping Agency, these ingredients are not typically classified as prohibited substances.


Q: Is Дип Хит the same as other rubs/creams for muscle pain?

Дип Хит is classified within the general category of External Analgesics and Topical Rubefacients. It is defined by its unique combination of four active ingredients, which differentiates its composition from other topical products in the same class.


Q: Can Дип Хит be used for pain in the feet or hands?

The product is approved for topical use on any 'affected area' of intact skin. Official regulatory documents do not list specific exclusions for non-broken skin on the hands or feet.


Q: Can I use Дип Хит if I'm taking oral pain medication?

Official documents state that use is restricted for patients taking oral anticoagulants (commonly called blood thinners). This is due to the potential for the product's active ingredient to be absorbed and increase the risk of bleeding.


Q: Does the medicine in Дип Хит get absorbed deeply into the body?

The product's immediate sensation comes from activating superficial nerve receptors, which is known as counter-irritation. While some ingredients can be systemically absorbed, especially with excessive use, the primary intended action is localized to the site of application.


Q: Can I use Дип Хит if I have sensitive skin?

Official product information notes that temporary adverse skin reactions may occur, such as a burning sensation, redness, or rash. These effects are noted to occur particularly if an individual has sensitive skin.


Q: Is it true that Дип Хит works by distracting from pain rather than treating it?

Studies and official information indicate that the product works through a dual-mechanism. It both distracts the sensation of pain (counter-irritation) and acts on the underlying inflammatory pathways, according to regulatory descriptions.


Q: What should be done if too much Дип Хит is applied?

If an excessive amount of the cream is accidentally applied, the official instruction is to use a tissue to wipe off the excess. If the cream is accidentally swallowed, official instructions state that contact with a doctor or hospital should be initiated immediately.


Q: Is it normal for the warming feeling to vary in intensity?

Regulatory documentation suggests that localized effects, including the temporary warming sensation or skin redness, may be heightened by certain use contexts. These conditions include application in hot weather or immediately after a hot bath.


Q: Does sun exposure change the effects or safety of Дип Хит?

Official safety constraints restrict the treated area from being exposed to external heat sources, which includes devices like sunlamps. Heat exposure is known to increase skin absorption of the active ingredients and elevate the risk of adverse effects.


Q: Are there any reported cases of allergic reactions to Дип Хит?

Hypersensitivity (a severe reaction) to any of the ingredients, aspirin, or other NSAIDs is a listed contraindication. Additionally, documentation for this class of topical products has noted rare, serious skin injuries, including chemical burns.

How should Дип Хит be stored and disposed of?

Storage and Disposal Requirements

All Deep Heat preparations must be stored out of the sight and reach of children as required by regulatory standards for all medicines.

Storage and Stability Requirements Official Regulatory Statement
Temperature Requirements Store the product (Rub/Cream) below 25 C or 30 C depending on regional labeling.
Pressurised Container Rules Spray containers must be protected from sunlight and temperatures must not exceed 50 C.
Handling Restrictions Pressurised containers must not be pierced or burned, even after use.
Stability Restriction The product must not be used after the expiry date printed on the packaging.

Disposal Requirements: Any expired or unused Deep Heat product must be returned to a pharmacist for safe disposal and should not be discarded in household waste or wastewater, consistent with environmental protection guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Дип Хит found in:

A-Z Index: